About The Cover Artist
Guest Medical Editor's Page
Autoimmune Movement Disorders in Adults
As antibodies to neuronal targets are described, we see the clinical spectrum and pathophysiology of autoimmune movement disorders more clearly.
Bettina Balint, MD
Autoimmune Movement Disorders in Children
A clinical approach.
Monideep Dutt, MD; Jamika Hallman-Cooper, MD; Ekta Bery, MD; Mohammed Shahnawaz, MD; and Grace Gombolay, MD
Utility of Autoantibody Profiles
Algorithmic testing for autoantibody profiles is more sensitive than physician-selected single autoantibody testing.
Shailee S. Shah, MD, and Andrew McKeon, MD
Anti-N-Methyl D Aspartate Receptor Encephalitis
Encephalitis caused by antibodies to the N-methyl-D-aspartate receptor causes symptoms of movement disorders, seizure, and psychiatric disturbances.
Nidhiben Anadani, MD
Movement Disorders in Antiphospholipid Syndrome & Systemic Lupus Erythematosus
Several movement disorders are seen with APS and SLE, most commonly chorea.
Danielle S. Shpiner, MD; Crystal Dixon, MD; Melissa R. Ortega, MD; and Henry Moore, MD
Treatment consists of immunomodulatory therapies and symptom management.
Jakai D. Nolan, DO, MPH, and Jacqueline A. Nicholas, MD, MPH
Immune-Mediated Cerebellar Ataxias
Cerebellar ataxia may be a prominent feature in autoimmune encephalitis and paraneoplastic syndromes.
Fabio Fieni Toso, MD; Rene de Araújo Gleizer, MD; and Lívia Almeida Dutra, MD, PhD
Clinical Commentary: Stroke Care Reshuffles During COVID-19 Pandemic
“Time Is Brain” still applies.
David Z. Rose, MD
Epilepsy Essentials: EEG Findings Associated With COVID-19
Multiple EEG findings associated with COVID-19 suggest a potential prognostic role.
Michelle L. Dougherty, MD, FAES, FAAN
Headache Horizons: New and Emerging Acute Migraine Treatments
A roadmap to navigating the acute migraine care landscape with 6 guideposts.
Peter McAllister, MD